Where does Miracor Medical SA rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Miracor Medical SA ranks #11,351 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Miracor Medical SA hold?

Miracor Medical SA holds 27 US utility patents granted between 2019 and 2025, spanning 4 technology areas.

What is Miracor Medical SA's Innovation Score?

Miracor Medical SA has an Innovation Score of 42.0 out of 100 (top 32% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Miracor Medical SA's patent grant rate increasing or decreasing?

Miracor Medical SA's recent grant velocity is +600% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Miracor Medical SA's patents?

Miracor Medical SA's patents average 20.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Miracor Medical SA patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Miracor Medical SA

Q: What technology areas does Miracor Medical SA focus on?

Miracor Medical SA's top technology area is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor) with 27 patents, ranking #261 of 3,490 assignees active in that subclass. Grants appear in 4 CPC subclasses total.

USPTO PatentsView assignee record - 27 granted patents across 4 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Miracor ranks #11,351 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 4 technology areas.

#11,351
of 49,997 US assignees by volume: Top 32%
by Innovation Score (42.0/100): 20.6
avg claims per patent: +600%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R11351 · Foreign Corporation #11,351 · 27 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-DENSE · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 27 grants
UPPER-Q #11,351/49,997
PHOTO-FINISH Menarini Silicon…
CPC-NARROW A61M · 4 areas
INNOV-PAR 42.0/100
CLAIMS-DENSE 20.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +600% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Menarini Silicon Biosystems S.p.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Miracor’s 42.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.5 pts (27%) Velocity 11.1 pts (26%) Breadth 7.1 pts (17%) Claim depth 12.3 pts (29%)

Qualcomm Incorporated · highest

85
Bourgault Industries · near

42
Fresenius Vial SAS · near

42
Keeson Technology · near

42
Miracor Medical · this assignee

42
Schleuniger · near

42
3D Lighting… · lowest

7

What this shows Miracor's Innovation Score is 42.0/100 (top 32% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Miracor?

Each dot is one of Miracor’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Miracor’s own 20.6 claims/patent is ABOVE the 16.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Miracor vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Miracor's grants concentrate

Miracor Medical SA is a focused PatentsView assignee: 4 CPC subclasses with 100% of grants classified under A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor). Peak complete grant year is 2022 (7 grants) versus a trough of 2 in 2021. By volume, Miracor sits between Menarini Silicon Biosystems S.p.A. and National Defense Medical Center.

Miracor's three-year grant acceleration

Miracor Medical SA shows 15 grants in 2022–2024 against only 9 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Menarini Silicon…

27
Micron Devices

27
Miir Holdings

27
Mimecast Services

27
Mitsubishi Materi…

27
Morphotrak

27
Munters

27
National Defense…

27
Miracor Medical ◀

27

What this shows Miracor holds 27 patents at rank #11,351, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Miracor

By rank, the assignees closest to #11,351 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media Into)

Other assignees with the most granted patents in Miracor's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Miracor, neither rank-band nor same-CPC leaders (those blocks stay above). In A61M (Devices FOR Introducing Media Into), Miracor ranks #261 of 3,490 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (42 here).

Keeson Technology Corporation Limited 42 Bourgault Industries Ltd. 42 Schleuniger AG 42 Fresenius Vial SAS 42

Miracor's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

42 Top 32% higher than 68% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2019–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table

Miracor Medical SA patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2019	3	11.1%
2020	4	14.8%
2021	2	7.4%
2022	7	25.9%
2023	5	18.5%
2024	3	11.1%
2025partial year	3	11.1%

Which technologies does Miracor Medical SA patent most?

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 27

A61B - DIAGNOSIS; SURGERY; Identification 14

F04D - Non-positive-displacement Pumps 13

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 4

Top 4 of 4 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Miracor Medical SA's patent record in context - here's where to go next.

Miracor Medical SA's lead technology class is A61M (Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor), 100% of its portfolio - see every assignee active in that class. Explore A61M
Ranked #11,351 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Miracor Medical SA against Menarini Silicon Biosystems S.p.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.